Research ArticleArticle
Essential Role of Calmodulin in RyR Inhibition by Dantrolene
Ye Win Oo, Nieves Gomez-Hurtado, Kafa Walweel, Dirk F. van Helden, Mohammad S. Imtiaz, Bjorn C. Knollmann and Derek R. Laver
Molecular Pharmacology July 2015, 88 (1) 57-63; DOI: https://doi.org/10.1124/mol.115.097691
Ye Win Oo
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (Y.W.O., K.W., D.F.H., M.S.I., D.R.L.); and Division of Clinical Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee (N.G.-H., B.C.K.)
Nieves Gomez-Hurtado
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (Y.W.O., K.W., D.F.H., M.S.I., D.R.L.); and Division of Clinical Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee (N.G.-H., B.C.K.)
Kafa Walweel
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (Y.W.O., K.W., D.F.H., M.S.I., D.R.L.); and Division of Clinical Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee (N.G.-H., B.C.K.)
Dirk F. van Helden
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (Y.W.O., K.W., D.F.H., M.S.I., D.R.L.); and Division of Clinical Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee (N.G.-H., B.C.K.)
Mohammad S. Imtiaz
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (Y.W.O., K.W., D.F.H., M.S.I., D.R.L.); and Division of Clinical Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee (N.G.-H., B.C.K.)
Bjorn C. Knollmann
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (Y.W.O., K.W., D.F.H., M.S.I., D.R.L.); and Division of Clinical Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee (N.G.-H., B.C.K.)
Derek R. Laver
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (Y.W.O., K.W., D.F.H., M.S.I., D.R.L.); and Division of Clinical Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee (N.G.-H., B.C.K.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Dantrolene Inhibition Requires Calmodulin
Ye Win Oo, Nieves Gomez-Hurtado, Kafa Walweel, Dirk F. van Helden, Mohammad S. Imtiaz, Bjorn C. Knollmann and Derek R. Laver
Molecular Pharmacology July 1, 2015, 88 (1) 57-63; DOI: https://doi.org/10.1124/mol.115.097691
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement